INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,368,024 | -62.9% | 80,236 | -56.5% | 0.39% | -70.0% |
| Q4 2022 | $3,689,507 | -10.1% | 184,660 | -3.1% | 1.31% | -19.2% |
| Q3 2022 | $4,106,000 | -21.4% | 190,660 | -28.0% | 1.62% | -12.9% |
| Q2 2022 | $5,223,000 | -22.0% | 264,877 | -7.1% | 1.86% | -31.9% |
| Q1 2022 | $6,696,000 | +4.4% | 284,977 | +21.0% | 2.74% | -8.6% |
| Q4 2021 | $6,416,000 | -31.2% | 235,545 | -30.4% | 3.00% | -28.2% |
| Q3 2021 | $9,322,000 | -5.4% | 338,503 | -2.2% | 4.17% | -16.0% |
| Q2 2021 | $9,854,000 | -61.0% | 346,271 | -53.3% | 4.97% | -28.9% |
| Q1 2021 | $25,252,000 | +149.6% | 741,378 | +144.0% | 6.99% | -3.1% |
| Q4 2020 | $10,117,000 | -12.8% | 303,902 | -15.8% | 7.21% | -27.8% |
| Q3 2020 | $11,597,000 | +33.9% | 360,829 | +14.7% | 9.99% | +50.7% |
| Q2 2020 | $8,662,000 | +238.4% | 314,508 | +96.9% | 6.63% | +248.8% |
| Q1 2020 | $2,560,000 | +229.0% | 159,701 | +389.9% | 1.90% | +206.0% |
| Q4 2019 | $778,000 | – | 32,597 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |